色色啦

News

Artificial intelligence to assist the brain

Neuroscience and neurotechnology are gaining a fresh ally in the form of artificial intelligence, which can assess dementia risk and enhance the effectiveness of depression treatments.
Kuvituskuvassa on vaaleanpunaisella pohjalla mustavalkoiset ihmiskasvot ja niiden yl盲puolella sinis盲vyinen piirroskuva aivoista. Kasvojen ymp盲rill盲 on yksitt盲isi盲 sanoja kuten "jungle" ja "tomato" sek盲 aivos盲hk枚k盲yr盲盲 symboloiva aaltoviiva.
Illustration: Eeva Sivula.

The human brain consists of some 86 billion neurons, nerve cells that process and convey information through electrical nerve impulses. 

That鈥檚 why measuring neural electrical activity is often the best way to study the brain, says Hanna Renvall. She is Aalto University and HUS Helsinki University Hospital Assistant Professor in Translational Brain Imaging and heads the HUS BioMag Laboratory.

Electroencephalography, or EEG, is the most used brain imaging technique in the world. Renvall's favourite, however, is magnetoencephalography or MEG, which measures the magnetic fields generated by the brain鈥檚 electrical activity.  

MEG signals are easier to interpret than EEG because the skull and other tissues don鈥檛 distort magnetic fields as much. This is precisely what makes the technique so great, Renvall explains. 

鈥楳EG can locate the active part of the brain with much greater accuracy, at times achieving millimetre-scale precision.鈥

An MEG device looks a lot like bonnet hairdryers found in hair salons. The SQUID sensors that perform the measurements are concealed and effectively insulated inside the bonnet because they only function at truly freezing temperatures, close to absolute zero. 

The world's first whole-head MEG device was built by a company that emerged from Helsinki University of Technology鈥檚 Low Temperature Laboratory 鈥 and is now the leading equipment manufacturer in this field. 

MEG plays a major role in the European Union鈥檚 new AI-Mind project, whose Finnish contributors are Aalto and HUS. The goal of the 鈧14-million project is to learn ways to identify those patients, whose dementia could be delayed or even prevented.

For this to happen, neuroscience and neurotechnology need help from artificial intelligence experts. 

Fingerprinting the brain

Dementia is a broad-reaching neural function disorder that significantly erodes the sufferer鈥檚 ability to cope with everyday life. Some 10 million people are afflicted in Europe, and as the population ages this number is growing. The most common illness that causes dementia is Alzheimer鈥檚 disease, which is diagnosed in 70鈥80% of dementia patients.

Researchers believe that communication between neurons begins to deteriorate well before the initial clinical symptoms of dementia present themselves. This can be seen in MEG data鈥攊f you know what to look for.

MEG is at its strongest when measuring the brain鈥檚 response to stimuli like speech and touch that occur at specific moments and are repetitive.

Interpreting resting-state measurements is considerably more complex.

That鈥檚 why the AI-Mind project uses a tool referred to as the fingerprint of the brain. It was created when Renvall and Professor Riitta Salmelin and her colleagues began to investigate whether MEG measurements could detect a person鈥檚 genotype. More than 100 sibling pairs took part in the study that sat subjects in an MEG, first for a couple of minutes with their eyes closed and then for a couple of minutes with their eyes open. They also submitted blood samples for a simple genetic analysis. 

When researchers compared the graphs and genetic markers, they noticed that, even though there was substantial variance between individuals, siblings鈥 graphs were similar.

Next, Aalto University Artificial Intelligence Professor Samuel Kaski鈥檚group tested whether a computer could learn to identify graph sections that were as similar as possible between siblings while also being maximally different when compared to other test subjects.

The machine did it鈥攁nd more, surprisingly. 

鈥業t learned to distinguish the individual perfectly based on just the graphs, irrespective of whether the imaging had been performed with the test subject鈥檚 eyes open or closed,鈥 Hanna Renvall says.

鈥楩or humans, graphs taken with eyes closed or open look very different, but the machine could identify their individual features. We鈥檙e extremely excited about this brain fingerprinting and are now thinking about how we could teach the machine to recognise neural network deterioration in a similar manner.鈥

Kuvituskuvassa on mustavalkoiset ihmiskasvot ja niiden yl盲puolella vihre盲s盲vyinen piirroskuva aivoista. Kuvan sivussa on my枚s aivos盲hk枚k盲yr盲盲 symboloivia aaltoviivoja.
Illustration: Eeva Sivula.

Risk screening in one week 

A large share of dementia patients are diagnosed only after the disorder has already progressed, which explains why treatments tend to focus on managing late-stage symptoms. 

Earlier research has, however, demonstrated that many patients experience cognitive deterioration, such as memory and thought disorders, for years before their diagnosis.

One objective of the AI-Mind project is to learn ways to screen individuals with a significantly higher risk of developing memory disorders in the next few years from the larger group of those suffering from mild cognitive deterioration. 

Researchers plan to image 1,000 people from around Europe who are deemed at risk of developing memory disorders and analyse how their neural signals differ from people free from cognitive deterioration. AI will then couple their brain imaging data with cognitive test results and genetic biomarkers.

Researchers believe this method could identify a heightened dementia risk in as little as a week.

鈥業f people know about their risk in time, it can have a dramatic motivating effect,鈥 says Renvall, who has years of experience of treating patients as a neurologist.

Lifestyle changes like a healthier diet, exercise, treating cardiovascular diseases and cognitive rehabilitation can significantly slow the progression of memory disorders.

Better managing risk factors can give the patient many more good years, which is tremendously meaningful for individuals, their loved ones and society, as well, Renvall says. 

Identifying at-risk individuals will also be key when the first drugs that slow disease progression come on the market, perhaps in the next few years. Renvall says it will be a momentous event, as the medicinal treatment of memory disorders has not seen any substantial progress in the last two decades.

The new pharmaceuticals will not suit everybody, however. 

鈥楾hese drugs are quite powerful, as are their side effects鈥攖hat鈥檚 why we need to identify the people who can benefit from them the most,鈥 Renvall emphasises.

Zapping the brain 

Brain activity involves electric currents, which generate magnetic fields that can be measured from outside the skull. 

The process also works in the other direction, the principle on which transcranial magnetic stimulation (TMS) is based. In TMS treatments, a coil is placed on the head to produce a powerful magnetic field that reaches the brain through skin and bone, without losing strength. The magnetic field pulse causes a short, weak electric field in the brain that affects neuron activity. 

It sounds wild, but it鈥檚 completely safe, says Professor of Applied Physics Risto Ilmoniemi, who has been developing and using TMS for decades.

鈥楾he strength of the electric field is comparable to the brain鈥檚 own electric fields. The patient feels the stimulation, which is delivered in pulses, as light taps on their skin.鈥

Magnetic stimulation is used to treat severe depression and neuropathic pain. At least 200 million people around the world suffer from severe depression, while neuropathic pain is prevalent among spinal injury patients, diabetics and multiple sclerosis sufferers. Pharmaceuticals provide adequate relief to only half of all depression patients; this share is just 30% in the case of neuropathic pain sufferers.

How frequently pulses are given is based on the illness being treated. For depression, inter-neuron communication is stimulated with high-frequency pulse series, while less frequent pulses calm patient鈥檚 neurons for neuropathic pain relief. 

Stimulation is administered to the part of the brain where, according to the latest medical science, the neurons tied to the illness being treated are located.

About half of treated patients receive significant relief from magnetic stimulation. Ilmoniemi believes this could be much higher鈥攚ith more coils and the help of algorithms.

Kuvituskuvassa on mustavalkoinen kasvokuva ja sen yl盲puolella violettis盲vyinen piirroskuva aivoista. Kuvan sivussa on kaaviokuva, jossa alasp盲in osoittava k盲yr盲 sek盲 teksti "The pizza was too hot to sing".
Illustration: Eeva Sivula.

One-note clanger to concert virtuoso 

In 2018, the ConnectToBrain research project headed by Ilmoniemi was granted 鈧10 million in European Research Council Synergy funding, the first time that synergy funds were awarded to a project steered by a Finnish university. Top experts in the field from Germany and Italy are also involved.

The goal of the project is to radically improve magnetic stimulation in two ways: by building a magnetic stimulation device with up to 50 coils and by developing algorithms to automatically control the stimulation in real time, based on EEG feedback.

Ilmoniemi looks to the world of music for a comparison. 

鈥楾he difference between the new technology and the old is analogous to a concert pianist playing two-handed, continuously fine-tuning their performance based on what they hear, rather than hitting a single key while wearing hearing protection.鈥

Researchers have already used a two-coil device to demonstrate that an algorithm can steer stimulation in the right direction ten times faster than even the most experienced expert. This is just the beginning.

A five-coil device completed last year covers an area of ten square centimetres of cortex at a time. A 50-coil system would cover both cerebral hemispheres.   

Building this kind of device involves many technical challenges. Getting all these coils to fit around the head is no easy task, nor is safely producing the strong currents required.

Even once these issues are resolved, the hardest question remains: how can we treat the brain in the best possible way?

鈥榃hat kind of information does the algorithm need? What data should instruct its learning? It is an enormous challenge for us and our collaborators,鈥 Ilmoniemi says thoughtfully.

The project aims to build one magnetic stimulation device for Aalto, another for the University of T眉bingen in Germany and a third for the University of Chieti-Pescara in Italy. The researchers hope that, in the future, there will be thousands of such devices in operation around the world.

鈥楾he more patient data is accumulated, the better the algorithms can learn and the more effective the treatments will become.鈥

The machine learned to distinguish the individual perfectly based on just the graphs.

Hanna Renvall

Quantum optics sensors could revolutionise how we read neural signals 

Professor Lauri Parkkonen鈥檚 working group is developing a new kind of MEG device that adapts to the head size and shape and utilises sensors based on quantum optics. Unlike the SQUID sensors currently employed in MEG, they do not need to be encased in a thick layer of insulation, enabling measurements to be taken closer to the scalp surface. This makes it easier to perform precise measurements on children and babies especially.

The work has progressed at a brisk pace and yielded promising results: measurements made with optical sensors are already approaching the spatial accuracy of measurements made inside the cranium.  

Parkkonen believes that a MEG system based on optical sensors could also be somewhat cheaper and more compact and thus easier to place than traditional devices; such a MEG system could utilize a 鈥榩erson-sized鈥 magnetic shield instead of a large shielded room as the conventional MEG systems do.

鈥楾his would bring it into reach of more researchers and hospitals.鈥

This article has been published in the (issuu.com), April 2022.

Go to the Aalto University Magazine page

色色啦 to develop

Aalto University's public core funding from the Ministry of Education and Culture has decreased in real terms by more than one-third compared to 2010, when the university began its operations. As a society, we cannot afford to cut back on education and research.

To ensure groundbreaking research and bold, persistent innovators in the future, we must invest in both long-term fundamental research and targeted innovation efforts. 色色啦 and you鈥檒l invest in a future you can be proud of.

A collage of various letter 'A' designs in multiple colours, fonts, and styles, arranged in a grid pattern.

School of Science

Translating research findings into clinical patient care is a long process that builds on previous scientific advancements. Medical research and technological developments are advanced at the Department of Neuroscience and Biomedical Engineering, in the School of Science.

Gift Type
Choose Amount
Gift Amount
Choose Amount
Gift Amount
  • Updated:
  • Published:
Share
URL copied!

Read more news

Samu Taulu
Appointments, Research & Art Published:

Samu Taulu develops next-generation brain imaging methods

Associate Professor of neurostimulation and neuroimaging Samu Taulu develops more precise methods for understanding the brain
Winners on stage for the EAA best student paper award
Awards and Recognition, Research & Art Published:

EAA Best Paper and Presentation Award for Young Researchers for postdoctoral researcher Thomas Deppisch

The awarded work shows how speech can be made clearer in noisy environments while still preserving directional cues
Curly-haired woman speaks into a microphone indoors, standing next to a screen.
Research & Art Published:

Professor Hanna Maylett: 鈥淲ithout time spent together, a shared vision cannot emerge鈥

According to Hanna Maylett, associate professor of film directing, a director doesn鈥檛 need to know all the answers; rather, their role is to create a process through which those answers can be discovered together.
Alex and Lucie Lampen
Cooperation, Research & Art Published:

From humble beginnings to a captain of industry 鈥 a visionary鈥檚 final gift lives on at Aalto University

The Lamp茅n bequest supports Aalto University chemical engineering students and future professionals through scholarships. Honorary counsellor and Master of Science (Technology) in chemical engineering Aleksander Lamp茅n was a significant pioneer in the Finnish wood processing and cellulose industries. His legacy continues to promote internationalisation and high-quality research in the field of bioproduct technology. A donation 色色啦 University is an impactful investment in education, innovation and the renewal of society.